Search company, investor...

Skuldtech

skuldtech.com

Stage

Unattributed | Alive

Total Raised

$1.3M

Last Raised

$1.3M | 9 yrs ago

About Skuldtech

Skuldtech is a biotechnology company specialized in the discovery of new biological markers and the development of new diagnostic tests. Biomarkers identified and selected by the company's scientific team are derived from its technology platform. The technology platform associates high-throughput sequencing, quantitative RT-PCR, bioinformatics and biostatistics programs. It is the result of 14 years of development and technical expertise in analyzing gene expression. Leveraging its unique scientific expertise analyzing gene expression in blood cells and whole blood, Skuldtech focuses personalized medicine and the development of companion and patient stratification tests to meet the increasing need for new treatments that are better adapted to patient profiles.

Headquarters Location

1682, rue de la Valsière

Montpellier, 34184,

France

+33 (0)467 419 748

Missing: Skuldtech's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Skuldtech's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Skuldtech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Skuldtech is included in 1 Expert Collection, including Omics.

O

Omics

1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

Skuldtech Patents

Skuldtech has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

10/9/2013

7/4/2017

Dog diseases, Transcription factors, Horse anatomy, Inflammations

Grant

Application Date

10/9/2013

Grant Date

7/4/2017

Title

Related Topics

Dog diseases, Transcription factors, Horse anatomy, Inflammations

Status

Grant

Latest Skuldtech News

Skuldtech becomes Acobiom

Jul 8, 2014

Verify here. The information provided by BioPortfolio.com is not a substitute forprofessional medical advice, diagnosis or treatment. The BioPortfoliosite is sponsored BioPortfolio Limited with offices at Stafford House,10 Prince of Wales Road, Dorchester, DT1 1PW, England. If youare a legal copyright holder or a designated agent for such and you believe apost on this website falls outside the boundaries of “Fair Use” andlegitimately infringes on your or your client's copyright we may be contactedconcerning copyright matters at: priority@bioportfolio.com. All rights reserved. All other trademarks recognized. Copyright© 1997-2014 BioPortfolio Limited. Site developed by Alacrify Ltd .

Skuldtech Frequently Asked Questions (FAQ)

  • Where is Skuldtech's headquarters?

    Skuldtech's headquarters is located at 1682, rue de la Valsière, Montpellier.

  • What is Skuldtech's latest funding round?

    Skuldtech's latest funding round is Unattributed.

  • How much did Skuldtech raise?

    Skuldtech raised a total of $1.3M.

  • Who are the investors of Skuldtech?

    Investors of Skuldtech include Bpifrance.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.